深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2025-022 深圳诺普信作物科学股份有限公司 关于举行2024年度网上业绩说明会的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）已于 2025 年 4 月 25 日在巨潮资讯网上披露了《深圳诺普信作物科学股份有限公司 2024 年年度报告》 及《2024 年年度报告摘要》。为便于广大投资者更加全面深入的了解公司经营业 绩、发展战略等情况，公司定于 2025 年 5 月 26 日（星期一）下午 15:00-17:00 在 "价值在线"（www.ir-online.cn）小程序举行公司 2024 年度网上业绩说明会，与 投资者进行沟通和交流。 为广泛听取投资者的意见和建议，提前 48 小时向投资者征集问题，投资者可 通过下方两种参与方式提出所关注的问题，提问通道自发出公告之日起开放。 参与方式一：网址 https://eseb.cn/1oqoVqHyfFS； 参与方式二：微信扫描下方小程序码； 投资者依据提示，授权登入"价 ...

Group 1 - The core viewpoint of the article highlights the recent research conducted by Kaifeng Investment on a listed company, Nopoxin, focusing on its blueberry business and market strategies [1] - Nopoxin has made progress in branding and channel development for its blueberry business, with improved channel satisfaction and expanding export channels [1] - There is significant growth potential in technology breakthroughs, talent cultivation, and preservation techniques in the blueberry cultivation sector, particularly in overseas markets such as Southeast Asia, Japan, and Russia [1] - Blueberry prices are expected to gradually decline over the long term, leading to a healthier market characterized by differentiation in variety, quality, seasonality, and geography [1] - The company employs marketing strategies such as "selling well," branding, channel management, and planning to mitigate price fluctuations while optimizing cultivation in the best regions to reduce costs [1] - Nopoxin's premium brand "Aimei Zhuang" targets the high-end market, offering better quality and higher premiums [1] - The company faces challenges in land acquisition in Yunnan, but government support is seen as a favorable factor for securing land [1] - Despite increased production, costs are rising due to improvements in cultivation quality, talent reserves, and technological innovation [1] - Nopoxin's core advantages lie in scientific and technological innovation, pest and disease control, structural advantages, partnership systems, and the application of systematic and scalable tools [1] Group 2 - Kaifeng Investment is a macro-hedge fund management company that invests in global commodities, bonds, equity assets, and derivatives [2] - The company is a member of the China Fund Industry Association and the China Futures Association, with qualifications approved by the China Securities Investment Fund Association [2] - Kaifeng Investment has received multiple awards for its performance and scale in managing various funds, ranking among the top in its category in China [2] - The investment philosophy of Kaifeng Investment emphasizes that details conceal industrial secrets and research reveals value cores [2] - The company has a high-level research team of over 50 members focused on macro and industrial fundamental research, covering major trading varieties in domestic and international futures markets [2] - In 2016, Kaifeng Investment plans to strengthen communication and cooperation with real enterprises, providing comprehensive solutions including industrial consulting, hedging cooperation, and industrial funds [2]

暗盘资金一眼洞悉庄家意图>> 草甘膦板块尾盘拉升，江天化学（300927）涨停，和邦生物（603077）、诺普信（002215）、利尔化学 （002258）、润丰股份（301035）、广信股份（603599）等纷纷走高。 ...

Group 1: Brand and Channel Development - The company has made significant progress in brand and channel development, with a notable reduction in product loss rates and increased channel satisfaction [1] - Key channels such as JD.com and Sam's Club have exceeded expectations, and overseas export channels are gradually opening up, with more countries expected to be covered next year [1] Group 2: Blueberry Cultivation and Market Opportunities - There is substantial room for technological breakthroughs in blueberry cultivation, which could lead to significant profit growth [2] - The company is focusing on training skilled managers to improve the return on investment in blueberry farming [2] - Southeast Asia, Japan, and Russia present large untapped markets for blueberries, indicating future growth opportunities [2] Group 3: Price Trends and Market Dynamics - The blueberry market is expected to experience a long-term gradual price decline, which will stimulate greater consumer demand [3] - The market is becoming more favorable as blueberry consumption becomes more widespread in China and globally [3] Group 4: Marketing Strategies and Brand Positioning - The company's marketing strategy focuses on four key areas: product quality, branding, channel development, and planning [4] - The highest-end brand, "Ai Mei Zhuang," targets premium quality and higher price points [5] Group 5: Land Acquisition and Operational Challenges - The company faces challenges in land acquisition, with government support being a crucial factor in overcoming these difficulties [6] - Despite increased production, costs are rising due to the need for better quality control and talent development [7] Group 6: Competitive Advantages - The company emphasizes scientific innovation, achieving significant reductions in pesticide use through biological control methods [8] - Successful compliance with Japanese customs regulations has enhanced the recognition of the company's blueberry quality [8]

债权人可采用现场、邮寄、电子邮件或传真的方式进行债权申报，具体方式 如下： （双休日及法定节假日除外） 深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2025-021 深圳诺普信作物科学股份有限公司 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）于 2025 年 5 月 16 日召开 2024 年年度股东大会，会议审议通过了《关于 2023 年限制性股票激励计 划回购注销已不符合激励条件激励对象已获授但尚未解锁的限制性股票的议案》， 同意公司回购注销上述已不符合激励条件激励对象已获授但尚未解锁的限制性 股票，回购股份数量合计为 370,000 股，回购股份予以注销并减少公司注册资本。 注销完成后公司股份总数将变更为 1,004,821,310 股。 根据《中华人民共和国公司法》等相关法律、法规的规定，公司特此通知债 权人，自本通知公告之日起 45 日内，凭有效债权证明文件及凭证向公司要求清 偿债务或提供相应担保。债权人如逾期未向公司申报上述要求，不会因此影响其 债权的有效性 ...

Core Viewpoint - The domestic blueberry industry in China is rapidly growing, with companies like Noposion Agricultural Science Co., Ltd. playing a significant role in this transformation, as consumers shift from imported to locally produced blueberries [2][3]. Company Performance - Noposion achieved a revenue of 5.288 billion yuan in 2024, marking a year-on-year increase of 28.37%, and a net profit of 585 million yuan, up 148.10% [3]. - The fresh consumption business, primarily focused on blueberries, generated 2.139 billion yuan in revenue, reflecting a remarkable growth of 251.28%, accounting for 40.45% of total revenue [3]. Blueberry Production and Technology - The company plans to expand its blueberry planting area to approximately 35,000 to 40,000 mu (about 5,833 to 6,667 acres) by the 2025-2026 production season [3]. - The yield per mu is expected to increase from 1.3 tons in the 2023-2024 season to 1.4 tons in the 2024-2025 season, with a target of over 1.5 tons for the next year [3]. - Noposion's blueberries have a large fruit rate of nearly 70% for fruits with a diameter of over 18 mm, thanks to advanced selection and early promotion techniques [3]. Agricultural Technology and Innovation - Noposion leverages its agricultural technology advantages, employing a research team composed of experts who work closely in the field to enhance blueberry cultivation [4][5]. - The company has developed a new agricultural research system that integrates local and scientific expertise, focusing on various research projects to improve cultivation techniques [5]. - The industrialized agricultural model adopted by Noposion, including automated irrigation and fertilization systems, represents a significant shift from traditional farming practices [5]. Market Trends - The development of the blueberry industry in China is seen as a typical example of technology empowering agriculture, aligning with consumer trends towards fresh, high-quality domestic fruits over imported frozen options [5].

深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2025-020 深圳诺普信作物科学股份有限公司 二○二四年年度股东大会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误 导性陈述或重大遗漏。 特别提示： 1、本次股东大会以现场投票和网络投票相结合的方式召开。 2、本次股东大会无增加、变更、否决提案的情况，不涉及变更前次股东大 会决议。 一、会议召开和出席情况 1、会议召开情况 （1）现场召开时间：2025年5月16日（星期五）下午14:30 网络投票时间：2025年5月16日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为2025年5月 16日上午9:15-9:25，9:30-11:30，下午13:00-15:00；通过深圳证券交易所互 联网投票系统进行网络投票的具体时间为2025年5月16日上午9:15至下午15:00 的任意时间。 （2）召开地点：深圳市宝安区西乡水库路113号公司七楼会议室 （4）召集人：本公司第七届董事会 （5）会议主持人：公司董事长卢柏强先生 （6）本次会议通知及相关文件分别刊登在2025年4月25日《 ...

法律意见书 深圳市福田区深南大道6008号特区报业大厦42、41、31DE、2403、2405 电话(Tel):+86 755 83515666 传真(Fax):+86 755 83515333/83515090 网址(Website): www.grandall.com.cn 国浩律师（深圳）事务所 关于深圳诺普信作物科学股份有限公司 2024年年度股东大会的法律意见书 GLG/SZ/A2008/FY/2025-531 致：深圳诺普信作物科学股份有限公司 国浩律师（深圳）事务所（以下称"本所"）接受深圳诺普信作物科学股份有 限公司（以下称"公司"）的委托，指派本所律师出席公司2024年年度股东大会（以 下称"本次股东大会"），对本次股东大会的合法性进行见证。 本所律师根据《中华人民共和国公司法》（以下称"《公司法》"）、《上市 公司股东大会规则》（以下称"《股东大会规则》"）等法律、法规和规范性法律 文件以及《深圳诺普信作物科学股份有限公司章程》（以下称"《公司章程》"） 的规定，就公司本次股东大会的召集、召开程序、出席会议人员的资格、召集人 的资格、表决程序和表决结果等有关事宜出具本法律意见书。 本法律意 ...

深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2025-021 深圳诺普信作物科学股份有限公司 关于回购注销限制性股票暨减少注册资本的债权人通知公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）于 2025 年 5 月 16 日召开 2024 年年度股东大会，会议审议通过了《关于 2023 年限制性股票激励计 划回购注销已不符合激励条件激励对象已获授但尚未解锁的限制性股票的议案》， 同意公司回购注销上述已不符合激励条件激励对象已获授但尚未解锁的限制性 股票，回购股份数量合计为 370,000 股，回购股份予以注销并减少公司注册资本。 注销完成后公司股份总数将变更为 1,004,821,310 股。 根据《中华人民共和国公司法》等相关法律、法规的规定，公司特此通知债 权人，自本通知公告之日起 45 日内，凭有效债权证明文件及凭证向公司要求清 偿债务或提供相应担保。债权人如逾期未向公司申报上述要求，不会因此影响其 债权的有效性，相关债务（义务）将由公司根据原债权文件的约定继续 ...

Core Viewpoint - The company reported significant growth in its financial performance for 2024 and Q1 2025, with notable increases in revenue and net profit, driven by strong performance in fresh produce and pesticide formulation businesses [1][2]. Financial Performance - In 2024, the company achieved revenue of 5.29 billion yuan, a year-on-year increase of 28.4%, and a net profit of 580 million yuan, up 148.1% [1]. - For Q1 2025, revenue reached 2.1 billion yuan, reflecting a 15.0% year-on-year growth, with net profit at 630 million yuan, an increase of 38.0% [1]. Business Segments - The fresh produce segment saw a remarkable revenue increase of 251.28%, contributing to 40.5% of total revenue [2]. - The application of early harvesting technology improved gross margins in the planting business by 8 percentage points to 43.9% [2]. - The pesticide formulation business experienced over 30% revenue growth for major products like "Aifengshou" and "Maidongli," supported by a decline in raw material prices [2]. Operational Efficiency - The company expanded its key account (KA) customer base, with KA channel shipments exceeding 30% of total shipments [3]. - The expense ratios for sales, management, and finance in Q1 2025 were 7.7%, 5.9%, and 1.1%, respectively, showing a reduction compared to the previous year [3]. Future Outlook - The company anticipates an increase in blueberry planting area to over 35,000 acres, with a target yield of over 1.5 tons per acre, indicating continued growth in production [2]. - Revenue projections for 2025-2027 are estimated at 5.81 billion, 6.77 billion, and 7.31 billion yuan, with corresponding net profits of 829 million, 1.156 billion, and 1.33 billion yuan [3].